Granulocyte colony-stimulating factor receptor — Drug Target

All drugs that target Granulocyte colony-stimulating factor receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Leukocyte Growth Factor [EPC]

Marketed (7)

• Lonquex · Sicor Biotech UAB · Infectious Disease
• Neulasta · Columbia University · Hematology
• Neupogen · University of Chicago · Oncology
• Rolvedon · Spectrum Pharms · Leukocyte Growth Factor [EPC] · Oncology
  Rolvedon works by binding to the granulocyte colony-stimulating factor receptor, stimulating the production of white blood cells.
• Neulasta · Amgen · Leukocyte Growth Factor [EPC] · Hematology
  Neulasta stimulates the production of white blood cells by binding to their receptors.
• ROLVEDON · SPECTRUM PHARMS · Leukocyte Growth Factor [EPC] · Oncology
• FULPHILA · MYLAN GMBH · Leukocyte Growth Factor [EPC] · Hematology